Starling Oncology, Inc.
STLN$687M
Small CapNASDAQServices-Offices & Clinics of Doctors of Medicine🇺🇸North AmericaCERRITOS641 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
STLN News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Starling Oncology, Inc.'s next FDA catalyst?→
Starling Oncology, Inc.'s (STLN) next tracked catalyst is a Earnings expected November 12, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track STLN biotech catalysts?→
Add STLN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Starling Oncology, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply